Your browser is no longer supported. Please, upgrade your browser.
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.71 Insider Own0.38% Shs Outstand158.13M Perf Week-2.99%
Market Cap8.52B Forward P/E- EPS next Y-1.01 Insider Trans-16.03% Shs Float116.70M Perf Month-6.81%
Income-267.90M PEG- EPS next Q-0.47 Inst Own96.80% Short Float5.42% Perf Quarter28.73%
Sales419.10M P/S20.34 EPS this Y17.50% Inst Trans0.09% Short Ratio6.40 Perf Half Y20.75%
Book/sh4.14 P/B12.76 EPS next Y45.10% ROA-34.70% Target Price61.84 Perf Year29.52%
Cash/sh3.99 P/C13.23 EPS next 5Y25.00% ROE-40.30% 52W Range30.02 - 58.72 Perf YTD-1.18%
Dividend- P/FCF- EPS past 5Y-10.90% ROI-35.40% 52W High-10.03% Beta1.24
Dividend %- Quick Ratio7.90 Sales past 5Y390.00% Gross Margin95.10% 52W Low75.98% ATR1.87
Employees580 Current Ratio7.90 Sales Q/Q27.50% Oper. Margin-65.80% RSI (14)47.54 Volatility2.94% 3.61%
OptionableYes Debt/Eq0.00 EPS Q/Q-86.10% Profit Margin-63.90% Rel Volume0.57 Prev Close52.01
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout- Avg Volume989.75K Price52.83
Recom1.60 SMA20-1.68% SMA50-1.46% SMA20011.28% Volume562,747 Change1.58%
Dec-16-20Initiated Mizuho Buy $69
Nov-16-20Upgrade Raymond James Outperform → Strong Buy $65
Aug-25-20Initiated Raymond James Outperform $65
Aug-20-20Initiated Morgan Stanley Overweight $55
Jul-07-20Upgrade Stifel Hold → Buy $41 → $71
Apr-16-20Initiated Jefferies Buy $60
Mar-31-20Upgrade Goldman Neutral → Buy $45 → $72
Mar-06-20Initiated Citigroup Buy $69
Dec-16-19Initiated Guggenheim Buy $60
Oct-24-19Initiated Oppenheimer Perform $44
Oct-01-19Initiated RBC Capital Mkts Outperform $60
Sep-13-19Upgrade SVB Leerink Mkt Perform → Outperform
Sep-10-19Upgrade Canaccord Genuity Hold → Buy $29 → $50
Jul-23-19Reiterated Needham Buy $40 → $34
Dec-10-18Initiated Canaccord Genuity Hold $23
Sep-21-18Upgrade Piper Jaffray Neutral → Overweight
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Jan-11-21 01:31PM  
Dec-22-20 09:00AM  
Dec-15-20 02:34PM  
Dec-04-20 11:31AM  
Nov-24-20 11:21PM  
Nov-11-20 03:15AM  
Nov-10-20 09:00AM  
Nov-05-20 12:45PM  
06:07AM  
Nov-04-20 05:55PM  
04:05PM  
02:30PM  
Oct-28-20 12:32PM  
Oct-26-20 10:02PM  
09:00AM  
Oct-21-20 04:05PM  
Oct-14-20 04:05PM  
Oct-01-20 09:00AM  
Sep-07-20 05:15PM  
Sep-05-20 08:47AM  
Sep-04-20 11:31AM  
Sep-02-20 09:00AM  
Aug-31-20 09:00AM  
Aug-26-20 10:44PM  
01:01PM  
Aug-25-20 09:35AM  
09:00AM  
Aug-24-20 07:08AM  
Aug-23-20 11:33AM  
Aug-20-20 09:51AM  
Aug-12-20 09:00AM  
Aug-06-20 01:19PM  
Aug-05-20 06:25PM  
04:05PM  
Jul-31-20 08:00PM  
Jul-30-20 03:37PM  
Jul-29-20 12:33PM  
09:00AM  
Jul-28-20 11:33AM  
Jul-22-20 04:05PM  
12:32PM  
Jul-21-20 04:24PM  
03:46AM  
Jul-20-20 05:30PM  
04:03PM  
04:02PM  
Jul-12-20 08:54PM  
Jul-08-20 06:51AM  
Jul-07-20 10:42AM  
Jun-29-20 03:50PM  
Jun-17-20 07:36PM  
Jun-16-20 10:47AM  
06:00AM  
Jun-15-20 09:00AM  
Jun-08-20 03:37AM  
Jun-06-20 11:31AM  
Jun-02-20 09:00AM  
07:27AM  
May-28-20 09:00AM  
May-27-20 12:15PM  
May-26-20 09:00AM  
May-21-20 11:28PM  
09:00AM  
May-09-20 08:02AM  
May-08-20 10:31PM  
10:55AM  
May-07-20 06:10PM  
04:06PM  
04:05PM  
May-05-20 04:05PM  
Apr-30-20 12:34PM  
Apr-15-20 04:05PM  
Apr-13-20 09:43AM  
Mar-27-20 11:31AM  
Mar-24-20 04:23PM  
Mar-22-20 05:04PM  
Mar-20-20 02:11PM  
Mar-17-20 12:06AM  
Mar-03-20 05:50PM  
Feb-28-20 08:35PM  
01:54PM  
Feb-27-20 11:13AM  
Feb-26-20 05:35PM  
04:05PM  
Feb-24-20 09:00AM  
Feb-19-20 12:31PM  
Feb-12-20 09:00AM  
Feb-05-20 06:13AM  
Jan-29-20 05:00AM  
Jan-17-20 08:45AM  
Jan-10-20 11:54AM  
Jan-07-20 09:00AM  
Dec-23-19 02:47PM  
11:30AM  
Dec-22-19 07:12AM  
Dec-19-19 10:18AM  
Dec-18-19 04:05PM  
Dec-17-19 09:11AM  
Dec-12-19 11:56AM  
Dec-11-19 09:04AM  
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stankovic Srdjan R.PresidentJan 12Option Exercise18.1270012,68420,947Jan 14 07:03 PM
Stankovic Srdjan R.PresidentJan 12Sale55.0170038,50720,247Jan 14 07:03 PM
Stankovic Srdjan R.PresidentJan 08Option Exercise27.4429,733815,98849,980Jan 08 07:28 PM
Stankovic Srdjan R.PresidentJan 08Sale55.2229,7331,641,83220,247Jan 08 07:28 PM
Stankovic Srdjan R.PresidentJan 07Option Exercise35.8061,6192,205,96081,866Jan 08 07:28 PM
Stankovic Srdjan R.PresidentJan 07Sale55.1261,6193,396,18720,247Jan 08 07:28 PM
YANG MICHAEL J.EVP and CCOJan 06Sale53.341,12059,7418,059Jan 08 07:31 PM
KIM AUSTIN D.EVP & General CounselJan 06Sale53.3467836,1655,518Jan 08 07:30 PM
Ridloff ElenaEVP and CFOJan 06Sale53.341,01654,1933,901Jan 08 07:29 PM
Stankovic Srdjan R.PresidentJan 06Sale53.341,72592,01220,247Jan 08 07:28 PM
DAVIS STEPHENCEOJan 06Sale53.343,484185,83724,482Jan 08 07:28 PM
Stankovic Srdjan R.PresidentNov 20Sale53.502,728145,94816,528Nov 20 09:29 PM
KIM AUSTIN D.EVP & General CounselOct 27Option Exercise17.588,750153,82512,601Oct 29 04:12 PM
KIM AUSTIN D.EVP & General CounselOct 27Sale45.108,750394,6363,851Oct 29 04:12 PM
YANG MICHAEL J.EVP and CCOOct 16Sale42.561,24753,0726,457Oct 19 05:27 PM
Stankovic Srdjan R.PresidentOct 16Sale42.561,29755,20013,006Oct 19 05:26 PM
DAVIS STEPHENCEOOct 16Sale42.562,960125,97814,786Oct 19 05:25 PM
YANG MICHAEL J.EVP and CCOJul 07Option Exercise23.0027,250626,77032,454Jul 09 06:26 PM
YANG MICHAEL J.EVP and CCOJul 07Sale56.2527,2501,532,7865,204Jul 09 06:26 PM
Stankovic Srdjan R.PresidentJun 19Option Exercise18.1216,452298,11027,786Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 19Sale50.1216,452824,51511,334Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Option Exercise18.8165,8431,238,69777,177Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Sale50.0165,8433,292,72911,334Jun 19 06:55 PM
DAVIS STEPHENCEOMay 14Option Exercise19.6588,5421,739,850100,351May 15 07:11 PM
DAVIS STEPHENCEOMay 14Sale45.6288,5424,039,10511,809May 15 07:11 PM
DAVIS STEPHENCEOMay 13Option Exercise19.65111,4582,190,150123,267May 15 07:11 PM
DAVIS STEPHENCEOMay 13Sale46.35111,4585,165,58711,809May 15 07:11 PM
Daly James MDirectorMay 11Option Exercise26.3926,250692,70026,250May 13 06:00 PM
Daly James MDirectorMay 11Sale51.1326,2501,342,1780May 13 06:00 PM
Stankovic Srdjan R.PresidentApr 30Sale49.214,308211,99711,334May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 30Sale49.221,05051,6812,195May 01 06:00 PM
DAVIS STEPHENCEOApr 30Sale49.216,770333,15211,809May 01 06:00 PM
YANG MICHAEL J.EVP and CCOApr 30Sale49.211,50173,8645,204May 01 06:00 PM
KIM AUSTIN D.EVP & General CounselApr 30Sale49.221,07252,7642,441May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Option Exercise25.1210,000251,20010,000May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Sale50.7410,000507,3530May 01 06:00 PM
Stankovic Srdjan R.PresidentApr 23Option Exercise20.6718,949391,70424,976Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 23Sale50.0718,949948,7296,027Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 22Option Exercise19.7754,0191,067,95660,046Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 22Sale50.0254,0192,701,9066,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Option Exercise19.65100,0001,965,000106,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Sale50.15100,0005,015,4506,027Apr 22 06:30 PM
BAKER BROS. ADVISORS LPDirectorMar 18Buy33.52135,8974,555,10138,433,977Mar 18 06:47 PM
BAKER BROS. ADVISORS LPDirectorMar 17Buy32.84219,8007,218,90738,309,339Mar 18 06:47 PM
BAKER BROS. ADVISORS LPDirectorMar 16Buy31.51694,30321,878,01738,107,749Mar 18 06:47 PM